All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-20160279

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	20160279	C1653T	X	X	Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
2	20160279	A1762T	BCP		Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
3	20160279	G1764A	BCP		Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
4	20160279	G1896A	PreC	C	Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
5	20160279	T1753V	BCP		Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
6	20160279	T31C	PreS2	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
7	20160279	T53C	PreS	S	Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
8	20160279	C1766T	BCP		Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View
9	20160279	G1899A	PreC	C	Hepatitis B Virus Infection Carcinoma, Hepatocellular	L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.